Dr. Nasser Altorki is a professor of Cardiothoracic Surgery and the Director of the Division of Thoracic Surgery at NewYork Presbyterian-Weill Cornell Medical Center. He is also the David B. Skinner, M.D. Professor of Thoracic Surgery at Weill Cornell Medical College, Cornell University, and an Attending Cardiothoracic Surgeon at NewYork-Presbyterian Hospital.
He received his medical degree from the University of Cairo, Faculty of Medicine in 1977. He completed his residency in general surgery and a fellowship in Thoracic and Cardiovascular Surgery at the University of Chicago Hospital.
His main clinical interests are minimally invasive lung and esophageal surgery, lung cancer, esophageal cancer, and various esophageal diseases such as gastroesophageal reflux, esophageal motor disorders, Barrett's esophagus, paraesophageal hernia, and achalasia. He also specializes in the treatment of thymoma and mediastinal tumors. His research focuses on lung cancer immunotherapy and prevention, the biology, staging and therapy for esophageal carcinoma, and new clinical trials in cancer.
Selected publications from PubMed
The Society of Thoracic Surgeons Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-Small Cell Lung Cancer.
Khullar OV, Kidane B, Altorki N, Antonoff M, Axtell AL, Kim SS, Krantz SB, Mitzman B, Raymond DP, Seder CW, Sood P, Towe CW, Wakwe WC, Crabtree T, Hayanga JWA
Ann Thorac Surg. 2026 Sep;122(3):531-548 doi: 10.1016/j.athoracsur.2026.06.015.
Role of Lung Marking in the Age of Sublobar Resection.
Ali MS, Altorki N, Musani A, Ghori U, Bawaadam H
Respirology. 2026 Aug 17 doi: 10.1002/resp.70301.
Beyond R0: Margin Cytology and Local Control After Sublobar Resection.
Baiu I, Altorki NK, Kneuertz PJ
Ann Thorac Surg. 2026 Jul 2 pii: S0003-4975(26)00700-9. doi: 10.1016/j.athoracsur.2026.06.047.
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.
Kuo HH, Bhinder B, Gokozan HN, Gorski K, Chandra P, Manohar J, Guevara D, Otilano J, Moyer J, Tranquille M, Ackermann S, Capuano J, Cheung C, Caiazza TA, Reuben PL, Tsomides AM, Irizarry A, Sigouros M, Wilkes D, King A, Kane T, Al Assaad M, Al Zoughbi W, Ohara K, Auh J, Waltman P, Madorsky Rowdo FP, Podaza E, Gallegos V, Nguyen J, Shah R, Shah M, Ocean A, Scherr D, Altorki N, Frey M, Molina AM, Newman L, Bea V, Chapman-Davis E, Goncalves MD, Saxena A, Shukla PJ, Holcomb K, Simmons R, Tagawa S, Zippin JH, Cantillo E, Chandwani R, Davis M, Garrett K, Kasi PM, Marti J, Nanus D, Nauseef JT, Popa E, Siddiqui MT, Alonso A, Sternberg CN, Faltas BM, Elemento O, Mosquera JM, Sboner A, Martin ML
Sci Adv. 2026 Jun 26;12(26):eadz3351 doi: 10.1126/sciadv.adz3351.
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC.
Podaza E, Capuano J, Kuo HH, Al Assaad M, Markowitz G, Revuelta MV, Nguyen J, Irizarry A, Ravichandran H, Ackermann S, Kane T, Manohar J, Duren-Lubanski A, Sigouros M, Moyer J, Bhinder B, Chandra P, Malbari M, Boehnke K, Mosquera JM, Mittal V, Sboner A, Gokozan H, Altorki N, Elemento O, Martin ML
Cell Rep Methods. 2026 Jun 15;6(6):101339 doi: 10.1016/j.crmeth.2026.101339.
Help your network discover Dr. Nasser Altorki's clinical expertise.
